BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7009139)

  • 1. alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Feb; 21(2):81-9. PubMed ID: 7009139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alpha-methyl-paratyrosine in the treatment of malignant pheochromocytoma].
    Decoulx M; Wemeau JL; Racadot-Leroy N; Grimbert I; Proye C; Plane C
    Rev Med Interne; 1987; 8(4):383-8. PubMed ID: 3423477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytoma resistant to alpha-adrenergic blockade.
    Hauptman JB; Modlinger RS; Ertel NH
    Arch Intern Med; 1983 Dec; 143(12):2321-3. PubMed ID: 6139989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of alpha-methyl-paratyrosine on the urinary excretion of catecholamines in patients with pheochromocytoma].
    Rivero Sánchez M; Selgas Gutiérrez R; Lorenzo Aguiar MD; Martínez Muñoz I; Beberide García JM; Almaraz Jiménez M; Rińon Aguilar C; Sánchez Sicilia L
    Rev Clin Esp; 1981 May; 161(4):235-9. PubMed ID: 7280330
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
    Robinson RG; DeQuattro V; Grushkin CM; Lieberman E
    J Pediatr; 1977 Jul; 91(1):143-7. PubMed ID: 17659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma.
    Ram CV; Meese R; Hill SC
    Arch Intern Med; 1985 Nov; 145(11):2114-5. PubMed ID: 2865938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metyrosine and pheochromocytoma.
    Steinsapir J; Carr AA; Prisant LM; Bransome ED
    Arch Intern Med; 1997 Apr; 157(8):901-6. PubMed ID: 9129550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
    Tcherdakoff P; Ménard J; Bedrossian J; Vaysse J; Alexandre JM; Milliez P
    Sem Hop; 1972 May; 48(25):1779-87. PubMed ID: 4405188
    [No Abstract]   [Full Text] [Related]  

  • 10. [A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
    Okada S; Ohshima K; Onai T; Umahara M; Kobayashi S; Ishihara H
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1221-5. PubMed ID: 1975832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of pheochromocytoma with the use of metyrosine.
    Perry RR; Keiser HR; Norton JA; Wall RT; Robertson CN; Travis W; Pass HI; Walther MM; Linehan WM
    Ann Surg; 1990 Nov; 212(5):621-8. PubMed ID: 1978640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of phaeochromocytoma, with development of metastases. Effect of treatment with alpha-methylparatyrosine.
    Janssens EN; Krenning EP; Derkx FH
    Neth J Med; 1981; 24(3):120-3. PubMed ID: 7254443
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and pharmacologic effects of alpha-methyltyrosine in man.
    Engelman K; Horwitz D; Jéquier E; Sjoerdsma A
    J Clin Invest; 1968 Mar; 47(3):577-94. PubMed ID: 5637145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-methyl-p-tyrosine in the symptomatic treatment of patients with malignant phaeochromocytoma.
    Pyörälä K; Pitkänen E; Toivonen S
    Ann Med Intern Fenn; 1968; 57(2):65-73. PubMed ID: 5706389
    [No Abstract]   [Full Text] [Related]  

  • 15. Phaeochromocytoma with myocarditis managed with alpha-methyl-p-tyrosine.
    Begnall WE; Salway JG; Jackson EW
    Postgrad Med J; 1976 Oct; 52(612):653-6. PubMed ID: 995792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant pheochromocytoma. Effect of oral alpha-methyl-p-tyrosine upon catecholamine metabolism.
    Hengstmann JH; Gugler R; Dengler HJ
    Klin Wochenschr; 1979 Apr; 57(7):351-5. PubMed ID: 108462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.
    Engelman K; Jéquier E; Udenfriend S; Sjoerdsma A
    J Clin Invest; 1968 Mar; 47(3):568-76. PubMed ID: 5637144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic blockade in pheochromocytoma.
    Modlinger RS; Ertel NH; Hauptman JB
    Arch Intern Med; 1983 Dec; 143(12):2245-6. PubMed ID: 6139986
    [No Abstract]   [Full Text] [Related]  

  • 19. Pheochromocytoma: urinary catecholamine excretion and insulin secretion after -methyl-p-tyrosine treatment.
    Parra A; Porcayo F; Santos D
    Helv Paediatr Acta; 1972 Jul; 27(3):309-14. PubMed ID: 4645656
    [No Abstract]   [Full Text] [Related]  

  • 20. An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside.
    Anton AH; Sherman BW; Lina AA; Acheson LS
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):89-92. PubMed ID: 8096204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.